Dr. Reddy's Laboratories has launched Over-the-Counter Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicorette Lozenges in the U.S. market. The Nicotine Lozenges brands and store brand markets had total U.S. retail sales of approximately $200 million for the most recent 52 weeks ending in May 17, 2020 according to IRI.
This launch truly demonstrates company’s ability to deliver on more complex dosage forms for the benefit of consumers who wish to quit smoking by reducing withdrawal symptoms, including nicotine cravings. The company’s Nicotine Polacrilex Lozenges are available in multiple pack sizes based on consumers’ requirements.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
